nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety
|
Mallet, Eric |
|
2004 |
22 |
11-12 |
p. 1343-1357 15 p. |
artikel |
2 |
Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster
|
Mallet, Eric |
|
2004 |
22 |
11-12 |
p. 1415-1422 8 p. |
artikel |
3 |
Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines
|
Leitner, Wolfgang W |
|
2004 |
22 |
11-12 |
p. 1537-1544 8 p. |
artikel |
4 |
Cell death induced by vaccine adjuvants containing surfactants
|
Yang, Ya-Wun |
|
2004 |
22 |
11-12 |
p. 1524-1536 13 p. |
artikel |
5 |
Editorial Board/Aims and Scope
|
|
|
2004 |
22 |
11-12 |
p. IFC- 1 p. |
artikel |
6 |
Erratum to “Loss of imunity to pertussis in a rural community in Senegal” [Vaccine 22 (2004) 594–596]
|
Broutin, Hélène |
|
2004 |
22 |
11-12 |
p. 1587- 1 p. |
artikel |
7 |
Erratum to “Unexpectedly high incidence of persistent itching nodules and delayed hypersensitivity to aluminium in children after the use of adsorbed vaccines from a single manufacturer” [Vaccine 22 (2004) 64–69]
|
Bergfors, Elisabet |
|
2004 |
22 |
11-12 |
p. 1586- 1 p. |
artikel |
8 |
Evaluation of the impact of an HMO’s varicella vaccination program on incidence of varicella
|
Mullooly, John P |
|
2004 |
22 |
11-12 |
p. 1480-1485 6 p. |
artikel |
9 |
Formalin-inactivated bovine RSV vaccine enhances a Th2 mediated immune response in infected cattle
|
Kalina, Warren V. |
|
2004 |
22 |
11-12 |
p. 1465-1474 10 p. |
artikel |
10 |
Fourth World Congress on Vaccines and Immunisation, 30 September-3 October 2004, Tsukuba Science City, Tokyo, Japan WCVI 2004 Japan
|
|
|
2004 |
22 |
11-12 |
p. I-II nvt p. |
artikel |
11 |
Gene immunization may induce secondary antibodies reacting with DNA
|
Isaguliants, Maria G |
|
2004 |
22 |
11-12 |
p. 1576-1585 10 p. |
artikel |
12 |
Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A
|
Tiberio, Lorrie |
|
2004 |
22 |
11-12 |
p. 1515-1523 9 p. |
artikel |
13 |
Immunisation against PCV2 structural protein by DNA vaccination of mice
|
Kamstrup, Søren |
|
2004 |
22 |
11-12 |
p. 1358-1361 4 p. |
artikel |
14 |
Immunization with heat-killed Mycobacterium bovis bacille Calmette–Guerin (BCG) in Eurocine™ L3 adjuvant protects against tuberculosis
|
Haile, M |
|
2004 |
22 |
11-12 |
p. 1498-1508 11 p. |
artikel |
15 |
Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice
|
Strindelius, Lena |
|
2004 |
22 |
11-12 |
p. 1448-1456 9 p. |
artikel |
16 |
Influence of routes and administration parameters on antibody response of pigs following DNA vaccination
|
Barfoed, Annette Malene |
|
2004 |
22 |
11-12 |
p. 1395-1405 11 p. |
artikel |
17 |
In vivo electroporation of skeletal muscles increases the efficacy of Japanese encephalitis virus DNA vaccine
|
Wu, Chang-Jer |
|
2004 |
22 |
11-12 |
p. 1457-1464 8 p. |
artikel |
18 |
Leptospiral immunoglobulin-like proteins elicit protective immunity
|
Koizumi, Nobuo |
|
2004 |
22 |
11-12 |
p. 1545-1552 8 p. |
artikel |
19 |
Localization of linear cytotoxic and pro-apoptotic epitopes in RTX toxin ApxIII of Actinobacillus pleuropneumoniae
|
Seah, J.N. |
|
2004 |
22 |
11-12 |
p. 1494-1497 4 p. |
artikel |
20 |
Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant
|
Soenawan, Elawati |
|
2004 |
22 |
11-12 |
p. 1553-1563 11 p. |
artikel |
21 |
Mechanism of adsorption of hepatitis B surface antigen by aluminum hydroxide adjuvant
|
Iyer, Seema |
|
2004 |
22 |
11-12 |
p. 1475-1479 5 p. |
artikel |
22 |
Mouse neurotoxicity test for vaccinia-based smallpox vaccines
|
Li, Zhongqi |
|
2004 |
22 |
11-12 |
p. 1486-1493 8 p. |
artikel |
23 |
Non-replicating mucosal and systemic vaccines: quantitative and qualitative differences in the Ag-specific CD8+ T cell population in different tissues
|
Qimron, Udi |
|
2004 |
22 |
11-12 |
p. 1390-1394 5 p. |
artikel |
24 |
Oral immunization of chickens with avirulent Salmonella vaccine strain carrying C. jejuni 72Dz/92 cjaA gene elicits specific humoral immune response associated with protection against challenge with wild-type Campylobacter
|
Wyszyńska, Agnieszka |
|
2004 |
22 |
11-12 |
p. 1379-1389 11 p. |
artikel |
25 |
Persistence of antibodies at 5–6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5–6 years of age
|
Langue, Jacques |
|
2004 |
22 |
11-12 |
p. 1406-1414 9 p. |
artikel |
26 |
Placental transfer of measles antibodies: effect of gestational age and maternal vaccination status
|
Linder, Nehama |
|
2004 |
22 |
11-12 |
p. 1509-1514 6 p. |
artikel |
27 |
Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles
|
Carcaboso, A.M |
|
2004 |
22 |
11-12 |
p. 1423-1432 10 p. |
artikel |
28 |
Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptides
|
Langhans, Bettina |
|
2004 |
22 |
11-12 |
p. 1441-1447 7 p. |
artikel |
29 |
Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography
|
Özcengiz, Erkan |
|
2004 |
22 |
11-12 |
p. 1570-1575 6 p. |
artikel |
30 |
Recombinant meningococcal PorA protein, expressed using a vector system with potential for human vaccination, induces a bactericidal immune response
|
Humphries, Holly E |
|
2004 |
22 |
11-12 |
p. 1564-1569 6 p. |
artikel |
31 |
Review of pneumococcal conjugate vaccine in adults: implications on clinical development
|
Abraham-Van Parijs, Betsy |
|
2004 |
22 |
11-12 |
p. 1362-1371 10 p. |
artikel |
32 |
Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus
|
Eblé, Phaedra L |
|
2004 |
22 |
11-12 |
p. 1372-1378 7 p. |
artikel |
33 |
Vaccination with inactivated murine gammaherpesvirus 68 strongly limits viral replication and latency and protects type I IFN receptor knockout mice from a lethal infection
|
Aricò, Eleonora |
|
2004 |
22 |
11-12 |
p. 1433-1440 8 p. |
artikel |
34 |
Viral Vaccine meeting held in Barcelona, October 25–28, 2003
|
Boon, A.C.M |
|
2004 |
22 |
11-12 |
p. 1327-1334 8 p. |
artikel |
35 |
What is vaccine advocacy?
|
Balinska, M.A. |
|
2004 |
22 |
11-12 |
p. 1335-1342 8 p. |
artikel |